NVTA News and Press, Invitae Corporation From 05/08/23

2023-05-08 10:34:40 ET This will surely be another wild week for investors. Regional bank stocks are surging to start the Monday session as cooler heads prevail after last week’s insanity. But then you’ve got upcoming catalysts like Wednesday’s May CPI inflation data, m...

Invitae to Announce First Quarter 2023 Financial Results on Tuesday, May 9, 2023 PR Newswire SAN FRANCISCO , April 26, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it will report its first quarte...

2023-04-21 21:52:11 ET Shares of Invitae Corporation (NYSE: NVTA) closed 11.57% higher on Friday after Cathie Wood, the CEO of Ark Invest, said the stock was undervalued. Wood's Ark Innovation ETF owns more than 18 million shares of Invitae, worth roughly $24 million as of Frida...

Invitae Publishes Annual Environmental, Social and Governance (ESG) Report PR Newswire – Report details the company's commitment to improve healthcare for all through its ESG and sustainability initiatives – SAN FRANCISCO , April 17, 2023 /PRNew...

New Study Findings Published in Nature Show Circulating Tumor DNA (ctDNA) Can Predict and Detect Cancer Recurrence Earlier In Non-Small Cell Lung Cancer PR Newswire – Highlights the use of Invitae's personalized cancer monitoring (PCM) technology to correlate clinical out...

2023-03-29 07:56:11 ET Summary GeneDx Holdings Corp. has had a dreadful performance as a stock. GeneDx's number of shares outstanding have absolutely exploded. GeneDx has a negative gross margin and is significantly burning cash. While its business model has merit, you nee...

Invitae and Deerfield Management Partner to Create Novel Therapeutics for Rare Diseases PR Newswire – The partnership will harness genetic and clinical data from millions of patients tested at Invitae and Deerfield's expertise in drug discovery to address high unmet needs...

2023-03-21 12:08:50 ET Genetics company Invitae ( NYSE: NVTA ) said it is collaborating with healthcare software company Epic to streamline genetic testing. Invitae will use Epic's specialty diagnostics suite Aura to streamline interactions with provider org...

Invitae Announces Partnership with Epic to Streamline Genetic Testing PR Newswire – Collaboration will simplify providers' and patients' access to discrete test results that can inform more precise, personalized medicine – SAN FRANCISCO , March 21, ...

Invitae Appoints Dr. W. Michael Korn as Chief Medical Officer for Oncology PR Newswire – Expert in the field of gastrointestinal cancer and precision oncology to lead Invitae's medical oncology team with a particular focus on somatic testing development – ...